Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Mar 1996, 184-190, Vol 3, No. 2
JR Creson, LC Lim, NJ Glowacki, SM Callister and RF Schell
Borreliacidal antibodies participate in the resolution of Lyme disease by
clearing Borrelia burgdorferi sensu lato from the host. Detection of
borreliacidal antibodies is also valuable for determination of the specific
serodiagnosis of Lyme disease. We show in this work that antibody detected
by the borreliacidal antibody test did not correlate with antibody detected
by the indirect fluorescent-antibody assay or Western immunoblotting.
Detection of borreliacidal antibody decreased with elimination of the
spirochete from the host in the presence or absence of therapy. By
contrast, the antibody responses detected by the indirect
fluorescent-antibody assay or Western immunoblotting remained elevated or
continued to expand, respectively. This suggests that the borreliacidal
antibody test is a prognostic indicator for clearance of the spirochete.
Additional investigations with humans are needed to confirm the prognostic
potential of the borreliacidal antibody test.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting
Wisconsin State Laboratory of Hygiene, University of Wisconsin, Madison 53706, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |